Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a nature photo make diabetes shots less scary?

NCT ID NCT06787859

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

People with type 2 diabetes often need daily insulin injections and blood sugar checks, which can cause pain and fear. Researchers are testing whether viewing a nature image on a screen for a few minutes before these procedures reduces pain and fear. The trial enrolls 64 adults with type 2 diabetes who use insulin and test their blood sugar at least twice a day. Half view the nature image before their procedures, and half receive standard care without it. Researchers measure pain with a visual scale and fear with a diabetes-specific questionnaire.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Nature image exposure
What this could lead to
If it helps, clinics could add a simple, low-cost visual distraction to routine diabetes care, making daily injections and finger-prick tests less stressful.
What could go wrong
The effect may be small or fade with repeated use, and the trial is small with only 64 participants. Distraction does not treat diabetes itself and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

64 people

The number who actually took part.

Started

Nov 2023

Finished

Nov 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Diagnosis of type 2 diabetes mellitus for at least one year Current use of insulin Ability to understand and speak Turkish No previous exposure to a nature image exposure intervention Performing insulin self-injection at least twice daily Performing self-monitoring of blood glucose at least twice daily Willingness to participate and provision of written informed consent Exclusion Criteria: Poor mental health Having gestational diabetes mellitus or Type 1 Diabetes Vertigo Visual impairment Hearing impairment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 2 diabetes mellitus (DM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dicle University Hospitals

    Diyarbakır, Di̇yarbakir, 21280, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.